Agile Therapeutics (AGRX) SEC Filings & 10K Form

$0.38
-0.02 (-5.03%)
(As of 05/17/2024 ET)

Recent Agile Therapeutics SEC Filings

DateFilerForm TypeView
04/09/2024
7:30 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
8:06 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
3:45 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:55 PM
Agile Therapeutics (Filer)
Form 424B5
02/23/2024
3:57 PM
Agile Therapeutics (Filer)
Form 424B5
02/15/2024
3:45 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:02 PM
Agile Therapeutics (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
02/06/2024
9:14 AM
Agile Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G/A
02/05/2024
8:21 AM
Agile Therapeutics (Filer)
Form S-1/A
12/20/2023
7:00 AM
Agile Therapeutics (Filer)
Form S-1/A
12/11/2023
4:30 PM
Agile Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/06/2023
7:00 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
7:00 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
7:15 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
3:45 PM
Agile Therapeutics (Issuer)
Coiante Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:30 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
3:50 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2023
7:30 AM
Agile Therapeutics (Filer)
Form 8-K/A
08/09/2023
7:10 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
3:50 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
3:36 PM
Agile Therapeutics (Issuer)
Gilmore Geoffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:37 PM
Agile Therapeutics (Issuer)
Conway Robert G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:37 PM
Agile Therapeutics (Issuer)
ALTOMARI ALFRED (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:38 PM
Agile Therapeutics (Issuer)
Korner Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:38 PM
Agile Therapeutics (Issuer)
Welsh Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
3:46 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
3:35 PM
Agile Therapeutics (Filer)
Form 8-K/A
06/09/2023
4:08 PM
Agile Therapeutics (Issuer)
BARBARI SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:09 PM
Agile Therapeutics (Issuer)
Carson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:10 PM
Agile Therapeutics (Issuer)
Hubbard John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:12 PM
Agile Therapeutics (Issuer)
Fischer Seth H. Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:13 PM
Agile Therapeutics (Issuer)
Torrente Josephine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:19 PM
Agile Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/05/2023
7:30 AM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
4:25 PM
Agile Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
11:27 AM
Agile Therapeutics (Filer)
Form 424B5
05/25/2023
11:29 AM
Agile Therapeutics (Filer)
Form 424B5
05/25/2023
11:25 AM
Agile Therapeutics (Filer)
Form 424B5
05/24/2023
3:05 PM
Agile Therapeutics (Filer)
Form 424B4
05/22/2023
11:15 PM
Agile Therapeutics (Filer)
Form EFFECT
Dems have chosen Biden replacement? (Ad)

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.
05/19/2023
11:20 AM
Agile Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AGRX) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners